Melatonin: A novel neuroprotectant for the treatment of glaucoma

Journal of Pineal Research

Volumn 48, Issue 4, 2010, Pages 353-364

  Belforte, Nicolás A ^a   Moreno, María C ^a   De Zavalía, Nuria ^a   Sande, Pablo H ^a   Chianelli, Mónica S ^a   Keller Sarmiento, María I ^a   Rosenstein, Ruth E ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Gamma aminobutyric acid; Glaucoma; Glutamate; Melatonin; Nitric oxide; Oxidative damage

Indexed keywords

4 AMINOBUTYRIC ACID; ARGININE; GLUTAMATE AMMONIA LIGASE; GLUTAMATE DECARBOXYLASE; GLUTAMIC ACID; GLUTATHIONE; HYALURONIC ACID; LIPID; MELATONIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR EYE CHAMBER; ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION (PARAMETERS); CONTINUOUS INFUSION; CONTROLLED STUDY; ELECTRORETINOGRAPHY; ENZYME ACTIVITY; GLAUCOMA; HISTOPATHOLOGY; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NONHUMAN; OPTIC NERVE DISEASE; OXIDATION REDUCTION STATE; RAT; RETINA GANGLION CELL;

ANIMALS; ARGININE; GAMMA-AMINOBUTYRIC ACID; GLAUCOMA; GLUTAMATE DECARBOXYLASE; GLUTAMIC ACID; HISTOCYTOCHEMISTRY; INTRAOCULAR PRESSURE; KINETICS; MALE; MELATONIN; NEUROPROTECTIVE AGENTS; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; RATS; RATS, WISTAR; RETINA; RETINAL GANGLION CELLS;

EID: 77950678465     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2010.00762.x     Document Type: Article

References (44)

1. Morrison JC, Pollack IP. Glaucoma: Science and Practice. Thieme Medical Publishers
2. Benozzi J, Nahum LP, Campanelli JL, Rosenstein RE. Effect of hyaluronic acid on intraocular pressure in rats. Invest Ophthalmol Vis Sci 2002 43 : 2196 2200.
3. Moreno MC, Marcos HJ, Croxatto JO et al. A new experimental model of glaucoma in rats through intracameral injections of hyaluronic acid. Exp Eye Res 2005 81 : 71 80.
4. Kaushik S, Pandav SS, Ram J. Neuroprotection in glaucoma. J Postgrad Med 2003 49 : 90 95.
5. Seki M, Lipton SA. Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma. Prog Brain Res 2008 173 : 495 510.
6. Moreno MC, Sande P, Marcos HA et al. Effect of glaucoma on the retinal glutamate/glutamine cycle activity. FASEB J 2005 19 : 1161 1162.
7. Belforte N, Moreno MC, Cymeryng C et al. Effect of ocular hypertension on retinal nitridergic pathway activity. Invest Ophthalmol Vis Sci 2007 48 : 2127 2133.
8. Moreno MC, De Zavalía N, Sande P et al. Effect of ocular hypertension on retinal GABAergic activity. Neurochem Int 2008 52 : 675 682.
9. Moreno MC, Campanelli J, Sande P et al. Retinal oxidative stress induced by high intraocular pressure. Free Radic Biol Med 2004 37 : 803 812.
10. Tan DX, Chen LD, Poeggeler B et al. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993 1 : 57 60.
11. Peyrot F, Ducrocq C. Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species. J Pineal Res 2008 45 : 235 246.
12. Hardeland R, Tan DX, Reiter RJ. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res 2009 47 : 109 126.
13. Reiter RJ, Paredes SD, Manchester LC, Tan DX. Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol 2009 44 : 175 200.
14. Sáenz DA, Turjanski AG, Sacca GB et al. Physiological concentrations of melatonin inhibit the nitridergic pathway in the Syrian hamster retina. J Pineal Res 2002 33 : 31 36.
15. Sáenz DA, Goldin AP, Minces L et al. Effect of melatonin on the retinal glutamate/glutamine cycle in the golden hamster retina. FASEB J 2004 18 : 1912 1913.
16. Sumioka K, Shirai Y, Sakai N et al. Induction of a 55-kDa PKN cleavage product by ischemia/reperfusion model in the rat retina. Invest Ophthalmol Vis Sci 2000 41 : 29 35.
17. Jaliffa CO, Sáenz D, Resnik E et al. Circadian activity of the GABAergic system in the golden hamster retina. Brain Res 2001 912 : 195 202.
18. Van Der Heyden JA, Korf J. Regional levels of GABA in the brain: rapid semiautomated assay and prevention of postmortem increase by 3-mercapto-propionic acid. J Neurochem 1978 31 : 197 203.
19. Bertilsson L, Mao CC, Costa E. Application of principles of steady-state kinetics to the estimation of gamma-aminobutyric acid turnover rate in nuclei of rat brain. J Pharmacol Exp Ther 1977 200 : 277 284.
20. 3H]- muscimol radioreceptor assay. J Neurochem 1980 34 : 614 618.
21. Morrison JC, Moore CG, Deppmeier LM et al. A rat model of chronic pressure-induced optic nerve damage. Exp Eye Res 1997 64 : 85 96.
22. Shareef SR, Garcia-Valenzuela E, Salieron A et al. Chronic ocular hypertension following episcleral venous occlusion in rats. Exp Eye Res 1995 61 : 379 382.
23. Ueda J, Sawaguchi S, Hanyu T et al. Experimental glaucoma model in the rat induced by laser trabecular photocoagulation after an intracameral injection of India ink. Jpn J Ophthalmol 1998 42 : 337 344. (Pubitemid 28498159)
24. Bettahi I, Pozo D, Osuna C et al. Melatonin reduces nitric oxide synthase activity in rat hypothalamus. J Pineal Res 1996 20 : 205 210.
25. Pozo D, Reiter RJ, Calvo JC, Guerrero JM. Inhibition of cerebellar nitric oxide synhtase and cyclic GMP production by melatonin via complex formation with calmodulin. J Cell Biochem 1997 65 : 430 442.
26. León J, Vives F, Crespo E et al. Modification of nitric oxide synthase activity and neuronal response in rat striatum by melatonin and kynurenine derivatives. J Neuroendocrinol 1998 10 : 297 302.
27. Das A, Belagodu A, Reiter RJ et al. Cytoprotective effects of melatonin on C6 astroglial cells exposed to glutamate excitotoxicity and oxidative stress. J Pineal Res 2008 45 : 117 124.
28. Rosenstein RE, Cardinali DP. Melatonin increases in vivo GABA accumulation in rat hypothalamus, cerebellum, cerebral cortex and pineal gland. Brain Res 1986 98 : 403 406.
29. Rosenstein RE, Estévez AG, Cardinali DP. Time-dependent effect of melatonin on glutamic acid decarboxylase activity and Cl influx in rat hypothalamus. J Neuroendocrinol 1989 1 : 443 447.
30. Ju WK, Kim KY, Angert M et al. Memantine blocks mitochondrial OPA1 and cytochrome c release and subsequent apoptotic cell death in glaucomatous retina. Invest Ophthalmol Vis Sci 2009 50 : 707 716.
31. Rodriguez C, Mayo JC, Sainz RM et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004 36 : 1 9.
32. León J, Acuña-Castroviejo D, Escames G et al. Melatonin mitigates mitochondrial malfunction. J Pineal Res 2005 38 : 1 9.
33. Guajardo MH, Terrasa AM, Catalá A. Protective effect of indoleamines on in vitro ascorbate-Fe2+ dependent lipid peroxidation of rod outer segment membranes of bovine retina. J Pineal Res 2003 35 : 276 282.
34. Liang FQ, Green L, Wang C et al. Melatonin protects human retinal pigment epithelial (RPE) cells against oxidative stress. Exp Eye Res 2004 78 : 1069 1075.
35. Siu AW, Reiter RJ, To CH. Pineal indoleamines and vitamin E reduce nitric oxide-induced lipid peroxidation in rat retinal homogenates. J Pineal Res 1999 2 : 122 128.
36. Celebi S, Dilsiz N, Yilmaz T, Kukner AS. Effects of melatonin, vitamin E and octreotide on lipid peroxidation during ischemia-reperfusion in the guinea pig retina. Eur J Ophthalmol 2002 12 : 77 83. (Pubitemid 34591094)
37. Aslan M, Cort A, Yucel I. Oxidative and nitrative stress markers in glaucoma. Free Radic Biol Med 2008 45 : 367 376.
38. Dubocovich ML. Melatonin receptors: multiple subtypes?. Trends Pharmacol Sci 1995 16 : 50 56.
39. Kiuchi Y, Mockovak ME, Gregory DS. Melatonin does not increase IOP significantly in rabbits. Curr Eye Res 1993 12 : 181 190.
40. Meyer-Bothling U, Bron AJ, Osborne NN. Topical application of serotonin or the 5-HT1-agonist 5-CT intraocular pressure in rabbits. Invest Ophthalmol Vis Sci 1993 34 : 3035 3042.
41. Pintor J, Martin L, Pelaez T et al. Involvement of melatonin MT(3) receptors in the regulation of intraocular pressure in rabbits. Eur J Pharmacol 2001 416 : 251 254.
42. Serle JB, Wang RF, Peterson WM et al. Effect of 5-MCA-NAT, a putative melatonin MT3 receptor agonist, on intraocular pressure in glaucomatous monkey eyes. J Glaucoma 2004 13 : 385 388.
43. Samples JR, Krause G, Lewy AJ. Effect of melatonin on intraocular pressure. Curr Eye Res 1988 7 : 649 653.
44. Marcic TS, Belyea DA, Katz B. Neuroprotection in glaucoma: a model for neuroprotection in optic neuropathies. Curr Opin Ophthalmol 2003 14 : 353 356.